COMPANY NEWS

3D Signatures Announces Changes to Its Board of Directors and Audit Committee

October 19, 2017
TORONTO, Oct. 19, 2017 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS") is pleased to...
Read More

3D Signatures Announces Completion of Stage 3 of Hodgkin’s Lymphoma Test Validation Program

October 10, 2017
Recent US Patent Issuances Strengthen Company's IP Portfolio TORONTO, Oct. 10, 2017 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the...
Read More

3D Signatures Announces Change to Its Board of Directors

October 10, 2017
TORONTO, Oct. 10, 2017 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), announces that Bruce...
Read More

3D Signatures Announces Close of Private Placement With Strategic Partner and Prospectus Update

October 4, 2017
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Oct. 04, 2017 (GLOBE...
Read More

3D Signatures Announces Private Placement With Strategic Partner and Prospectus Update

October 3, 2017
TORONTO, Oct. 03, 2017 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS") is pleased to...
Read More

3D Signatures Announces Change to Its Board of Directors

August 15, 2017
TORONTO, Aug. 11, 2017 -- 3D Signatures Inc. (TSX-V:DXD) (OTCQB:TDSGF; FSE:3D0) (the "Company" or "3DS"), announces that Helen Stevenson has...
Read More

3D SIGNATURES INC. ANNOUNCES SHORT FORM PROSPECTUS OFFERING TO RAISE UP TO C$5 MILLION

July 21, 2017
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, ON (July 19, 2017) −...
Read More

3D SIGNATURES ADVANCES HODGKIN’S LYMPHOMA TEST

June 8, 2017
TORONTO, ON (June 8, 2017) − 3D Signatures Inc. (TSXV:DXD; OTCQB:TDSGF; FSE:3D0) (the "Company" or "3DS"), is pleased to announce...
Read More

TeloView Measures Genomic Stability To Predict Disease Aggressiveness

May 15, 2017
TeloView Measures Genomic Stability To Predict Disease Aggressiveness Interview with Jason Flowerday READ FULL ARTICLE
Read More

3-D imaging of telomeres inside cells aids cancer diagnosis, treatment

May 8, 2017
3-D imaging of telomeres inside cells aids cancer diagnosis, treatment CEO Jason Flowerday explains how 3D Signatures technology can markedly...
Read More
1 2 3 8